0001181431-13-024865.txt : 20130502 0001181431-13-024865.hdr.sgml : 20130502 20130502204055 ACCESSION NUMBER: 0001181431-13-024865 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130430 FILED AS OF DATE: 20130502 DATE AS OF CHANGE: 20130502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Yarranton Geoffrey Thomas CENTRAL INDEX KEY: 0001555737 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35798 FILM NUMBER: 13809926 MAIL ADDRESS: STREET 1: KALOBIOS PHARMACEUTICALS, INC. STREET 2: 260 EAST GRAND AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KALOBIOS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001293310 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770557236 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 260 EAST GRAND AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650.243.3100 MAIL ADDRESS: STREET 1: 260 EAST GRAND AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 rrd378064.xml FORM 4 X0306 4 2013-04-30 0 0001293310 KALOBIOS PHARMACEUTICALS INC KBIO 0001555737 Yarranton Geoffrey Thomas C/O KALOBIOS PHARMACEUTICALS, INC. 260 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Scientific Officer Stock Option (right to buy) 6 2013-04-30 4 A 0 75000 0 A 2023-04-30 Common Stock 75000 75000 D The option shares will vest and become exercisable ratably over 36 months of continuous service after May 1, 2013. /s/ Geoffrey Yarranton 2013-05-02